SEC Form 4 · accession 0001179110-18-003688

Teladoc Health, Inc. · TDOC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — SVP - Business Development

Period of report

Mar 2, 2018

Accepted (ET)

Mar 6, 2018 · 7:16 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001477449

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Mar 2, 2018	M	16,404	$6.01	A	16,700	D
Common Stock	Mar 2, 2018	M	2,841	$12.21	A	19,541	D
Common Stock	Mar 2, 2018	S	19,245	$39.25	D	296	D
Common Stock	Mar 5, 2018	M	8,334	$22.30	A	8,630	D
Common Stock	Mar 5, 2018	S	8,334	$41.26	D	296	D
Common Stock	Mar 6, 2018	M	8,335	$22.30	A	8,631	D
Common Stock	Mar 6, 2018	S	8,631	$42.10	D	0	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Employee Stock Option (right to buy)^F1	$6.01	Mar 2, 2018	M	16,404	D	—	Dec 18, 2024	Common Stock	16,404	27,340	D
Employee Stock Option (right to buy)^F2	$12.21	Mar 2, 2018	M	2,841	D	—	Mar 7, 2026	Common Stock	2,841	23,672	D
Employee Stock Option^F3	$22.30	Mar 5, 2018	M	8,334	D	—	Mar 3, 2027	Common Stock	8,334	58,342	D
Employee Stock Option (right to buy)^F3	$22.30	Mar 6, 2018	M	8,335	D	—	Mar 3, 2027	Common Stock	8,335	50,007	D

F1The option vested as to 25% of the shares on December 18, 2015. The remainder of the shares vest in 36 equal monthly installments thereafter.
F2The option vested as to 25% of the shares on March 7, 2017. The remainder of the shares vest in 36 equal monthly installments thereafter.
F3The option vested as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter.